SPIA
HZNP

Steward Partners Investment Advisory’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Steward Partners Investment Advisory’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-62
Closed -$7.17K – 3636
2023
Q3 		$7.17K Hold
62
– – ﹤0.01% 2699
2023
Q2 		$6.38K Hold
62
– – ﹤0.01% 2713
2023
Q1 		$6.77K Hold
62
– – ﹤0.01% 2684
2022
Q4 		$7.06K Buy
62
+12
+24% +$997 ﹤0.01% 2650
2022
Q3 		$3K Sell
50
-11
-18% -$769 ﹤0.01% 2991
2022
Q2 		$5K Sell
61
-32
-34% -$3.03K ﹤0.01% 2794
2022
Q1 		$10K Buy
93
+43
+86% +$4.19K ﹤0.01% 2689
2021
Q4 		$5K Sell
50
-10
-17% -$1.09K ﹤0.01% 2862
2021
Q3 		$7K Sell
60
-250
-81% -$26K ﹤0.01% 2734
2021
Q2 		$29K Sell
310
-540
-64% -$49.7K ﹤0.01% 4324
2021
Q1 		$78.2K Buy
850
+285
+50% +$24.1K ﹤0.01% 1754
2020
Q4 		$41K Sell
565
-235
-29% -$17.5K ﹤0.01% 1761
2020
Q3 		$62K Buy
800
+715
+841% +$49.2K ﹤0.01% 1406
2020
Q2 		$5K Sell
85
-2,800
-97% -$120K ﹤0.01% 2301
2020
Q1 		$85K Sell
2,885
-50
-2% -$1.69K ﹤0.01% 1059
2019
Q4 		$106K Sell
2,935
-30
-1% -$920 ﹤0.01% 1117
2019
Q3 		$80K Sell
2,965
-226
-7% -$5.84K ﹤0.01% 1175
2019
Q2 		$76K Buy
+3,191
New +$80.9K ﹤0.01% 1177
2018
Q4 		– Sell
-3,238
Closed -$63K – 2536
2018
Q3 		$63K Sell
3,238
-179
-5% -$3.4K ﹤0.01% 1111
2018
Q2 		$57K Sell
3,417
-415
-11% -$6.33K ﹤0.01% 1059
2018
Q1 		$54K Buy
+3,832
New +$56.6K ﹤0.01% 980

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Steward Partners Investment Advisory's HZNP Position: Q4 2023 in Review

Steward Partners Investment Advisory sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 62 shares — an estimated $7.17K sold.

Steward Partners Investment Advisory first reported a position in HZNP in Q1 2018 and held it in 21 quarters. The position peaked at $106K in Q4 2019. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Steward Partners Investment Advisory reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 62 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $7.17K.
  • Steward Partners Investment Advisory first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2018 and held it in 21 quarters.
  • Steward Partners Investment Advisory's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $106K in Q4 2019.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2023, filed 12 Feb 2024.